Warner Bros. Discovery, Inc.
HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR

Last updated:

Abstract:

10-oxo-6,1-dihydrobenzo[e]pyrido[1,2-c][1,3]oxazine-9-carboxylic acid derivatives of formula (I) as hepatitis B surface antigen inhibitors or pharmaceutically acceptable salts thereof, and uses of a compound of formula (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof in preparation of medicaments for treatment of viral hepatitis B. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

9 Mar 2018

Issue date:

6 Feb 2020